Collectively, our data show that a 3-gene transcriptional signature can identify CD8+ TIL that recognize epitopes derived from diverse classes of tumor antigens, and that this MANAscore can be used to discover new biology related to checkpoint blockade response. Here, CD8A is linked to neoplasm.